Prenatal valproate exposure linked to increased autism risk

04/23/2013 | HealthDay News · Reuters

Children born to mothers who took valproate while pregnant had an almost threefold increased risk of having an autism spectrum disorder, a Danish study found. In some mothers who took the epilepsy drug during their pregnancy, the risk of having a child with autism was more than four times greater. The findings, based on 656,000 children born in Denmark between 1996 and 2006, appear in the Journal of the American Medical Association.

View Full Article in:

HealthDay News · Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA